PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Clinical trial at Emory University reveals twice-yearly injection to be 96% effective in HIV prevention

Clinical trial at Emory University reveals twice-yearly injection to be 96% effective in HIV prevention
2024-11-27
(Press-News.org)

For oral medications that prevent new HIV infection to be effective, the patient must take certain actions, including attending doctor’s visits every three months and – most importantly – consistency. 

These daily oral antiretrovirals, more commonly referred to as PrEP (pre-exposure prophylaxis), such as Truvada®, are extremely effective at HIV prevention, but only if they are taken daily as directed. Truvada’s efficacy is greatly compromised when taken inconsistently. 

However, results from a recent Gilead-funded clinical trial (Purpose-2) led by physicians at Emory University and Grady Health System indicate that a twice-yearly injection of Lenacapavir offers a 96% reduced risk of infection overall, making the injection significantly more effective than the daily oral PrEP. The findings were recently published in the New England Journal of Medicine.

“Seeing these high levels of efficacy – at almost 100% -- in an injectable that people only have to take every six months is incredible,” says Colleen Kelley, MD, lead author of the study and professor in the School of Medicine at Emory University. “This is a considerable and profound advancement in medicine, especially for people whose circumstances don’t allow them to take a daily oral medication, and for those among populations disproportionately impacted by HIV.”  

In the randomized, double-blind, Phase III clinical trial comparing the efficacy of the two medications, 99% of the participants in the Lenacapavir group did not acquire an HIV infection. During the trial, only two participants in the Lenacapavir group, comprised of 2,179 people, acquired HIV. This compares to nine new HIV infections in the Truvada®group, which had 1,086 people. The trial showed that adherence to the injectable was higher than of the daily oral pill. 

Kelley, also the co-director of the Emory Center for AIDS Research, and Associate Dean for Research for Emory at Grady adds that while PrEP is incredibly effective at preventing infection, part of what made the injection more effective in the clinical trial was the challenges associated with adherence to a daily oral pill. 

“What we see over time is that about half of people who start taking daily oral PrEP stop within a year due to various factors,” says Kelley, referencing healthcare disparities in general. “Having an effective injectable that is only needed twice annually is very significant for people who have trouble accessing healthcare or staying adherent to daily, oral pills.” 

The inclusion of racially, ethnically, and gender-diverse participants in the clinical trial was notable because it was representative of populations disproportionately impacted by HIV in real time. For example, the trial groups were comprised of cisgender men and gender-diverse people at 88 sites in Peru, Brazil, Argentina, Mexico, South Africa, Thailand, and the U.S. 

According to the study, the same populations that are disproportionately impacted by HIV are the same populations that have limited access to PrEP – or may have difficulty consistently taking the oral antiretroviral medication – ultimately highlighting the need for more options. The study also indicates that more than half of the new HIV infections nationwide in 2022 were among cisgender gay men, and 70% of those were among Black or Hispanic individuals. 

Valeria Cantos, MD, associate professor in the School of Medicine at Emory University, physician at Grady Memorial Hospital, and the principal investigator for the clinical trial at the Grady research site, emphasized the importance of having trials that include populations truly representative of the patients that Grady serves. 

“At Grady, our focus is on increased representation of underserved and vulnerable populations, acknowledging and addressing the distrust towards research held by some community members due to prior abuses or neglect of these populations by research institutions in the past,” Cantos says. “Grady is an established, trusted research site because of its commitment to equity.”

At the Grady clinical trial site, medical materials were available in Spanish, and bilingual staff members recruited and enrolled trial participants who only spoke Spanish. Cantos also indicated that the site enrolled participants who are representative of the populations that would benefit the most from Lenacapavir. In addition to Grady, the Hope Clinic and Emory Midtown Hospital were among the 88 sites supporting the clinical trial. 

“We are not reaching everyone we need to reach with our current HIV prevention interventions, such as those who are disproportionately impacted by HIV and health care disparities,” says Kelley. “For people that are unable to take the daily oral pills, the injectable agents can really give incredible efficacy and be a game changer in helping them stay HIV negative.”

Since the Phase III clinical trial has been completed and submitted by the FDA for consideration, Kelley is hopeful that Lenacapavir may be approved by 2025 for commercial use. 

““The results of this study add to the armamentarium of novel tools for HIV prevention. Long acting antiretrovirals offer new hope for those who are not able to take oral medications,” says Carlos del Rio, MD, chair of the Department of Medicine at Emory University School of Medicine. “The challenge is now to roll out and make these tools available and accessible in an equitable way— only then we will see new HIV infections dramatically decreased locally and globally,” adds del Rio, also co-director of the Emory Center for AIDS Research.  

CITATION: Colleen Kelley, et al. Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons. New England Journal of Medicine. Nov. 27, 2024. 10.1056/NEJMoa2411858

END


[Attachments] See images for this press release:
Clinical trial at Emory University reveals twice-yearly injection to be 96% effective in HIV prevention Clinical trial at Emory University reveals twice-yearly injection to be 96% effective in HIV prevention 2 Clinical trial at Emory University reveals twice-yearly injection to be 96% effective in HIV prevention 3

ELSE PRESS RELEASES FROM THIS DATE:

Discovering the traits of extinct birds

Discovering the traits of extinct birds
2024-11-27
Looking to inform the conservation of critically endangered bird species, University of Utah biologists completed an analysis identifying traits that correlate with all 216 bird extinctions since 1500. Species most likely to go extinct sooner were endemic to islands, lacked the ability to fly, had larger bodies and sharply angled wings, and occupied ecologically specific niches, according to research published this month. While some of these findings mirror previous research on extinct birds, they are the first to correlate bird traits with the timing of ...

Are health care disparities tied to worse outcomes for kids with MS?

2024-11-27
MINNEAPOLIS – People who develop multiple sclerosis (MS) as children and grow up in less advantaged neighborhoods may have a larger volume of inflammation and brain tissue loss on imaging than those who grow up in more advantaged neighborhoods, according to a study published in the November 27, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. MS rarely develops in children. About 5% of people with MS are diagnosed before age 18. In addition to neighborhood location, worse brain imaging outcomes were also seen ...

For those with CTE, family history of mental illness tied to aggression in middle age

2024-11-27
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, NOVEMBER 27, 2024 MINNEAPOLIS – People who have chronic traumatic encephalopathy (CTE) who have a family history of mental illness may have a higher risk of aggression in middle age, according to a study published in the November 27, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. CTE is a neurodegenerative disease associated with repeated head injuries, often seen in athletes and military personnel, that can lead to mood changes and dementia. “This ...

The sound of traffic increases stress and anxiety

The sound of traffic increases stress and anxiety
2024-11-27
Manmade sounds such vehicle traffic can mask the positive impact of nature soundscapes on people’s stress and anxiety, according to a new study published November 27, 2024, in the open-access journal PLOS ONE by Paul Lintott of the University of the West of England, U.K., and Lia Gilmour of the Bat Conservation Trust, U.K. Existing research shows that natural sounds, like birdsong, can lower blood pressure, heart, and respiratory rates, as well as self-reported stress and anxiety. Conversely, anthropogenic soundscapes, like traffic or aircraft noise, are hypothesized to have negative effects on human health and wellbeing in a variety ...

Global food yields have grown steadily during last six decades

Global food yields have grown steadily during last six decades
2024-11-27
Contrary to widespread concerns that global crop yields have stagnated in recent decades, a comprehensive study of worldwide food production finds yields have continued to grow at roughly the same rate since the 1960s. John Baffes of the World Bank and Xiaoli Etienne of the University of Idaho, U.S., report these findings on November 27, 2024, in the open-access journal PLOS ONE.  Almost 10 billion people are expected to inhabit Earth by 2050, so agricultural production will become increasingly critical ...

Children who grow up with pets or on farms may develop allergies at lower rates because their gut microbiome develops with more anaerobic commensals, per fecal analysis in small cohort study

Children who grow up with pets or on farms may develop allergies at lower rates because their gut microbiome develops with more anaerobic commensals, per fecal analysis in small cohort study
2024-11-27
Children who grow up with pets or on farms may develop allergies at lower rates because their gut microbiome develops with more anaerobic commensals, per fecal analysis in small cohort study ### Article URL:  https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0313078 Article Title: Gut microbiota markers in early childhood are linked to farm living, pets in household and allergy Author Countries: Sweden Funding: This work was supported by the Region Västra Götaland (agreement concerning medical research and education – ALF), https://www.alfvastragotaland.se [ALFGBG966243] [ALFGBG720181] ...

North American Early Paleoindians almost 13,000 years ago used the bones of canids, felids, and hares to create needles in modern-day Wyoming, potentially to make the tailored fur garments which enabl

North American Early Paleoindians almost 13,000 years ago used the bones of canids, felids, and hares to create needles in modern-day Wyoming, potentially to make the tailored fur garments which enabl
2024-11-27
North American Early Paleoindians almost 13,000 years ago used the bones of canids, felids, and hares to create needles in modern-day Wyoming, potentially to make the tailored fur garments which enabled their dispersal into these colder climates ### Article URL:  https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0313610 Article Title: Early Paleoindian use of canids, felids, and hares for bone needle production at the La Prele site, Wyoming, USA Contact: Spencer Pelton, spencer.pelton@wyo.gov, Ph. +1 307 399 2827 Author Countries: U.S. Funding: Funding for this project includes the National Science Foundation (award #1947297), the ...

Higher levels of democracy and lower levels of corruption are associated with more doctors, independent of healthcare spending, per cross-sectional study of 134 countries

2024-11-27
Higher levels of democracy and lower levels of corruption are associated with more doctors, independent of healthcare spending, per cross-sectional study of 134 countries. ### Article URL: https://journals.plos.org/globalpublichealth/article?id=10.1371/journal. pgph.0003656 Article Title: The relationship between democracy and corruption and the global physician workforce Author Countries: Canada Funding: The authors received no specific funding for this work. END ...

In major materials breakthrough, UVA team solves a nearly 200-year-old challenge in polymers

In major materials breakthrough, UVA team solves a nearly 200-year-old challenge in polymers
2024-11-27
Researchers at the University of Virginia School of Engineering and Applied Science have developed a new polymer design that appears to rewrite the textbook on polymer engineering. No longer is it dogma that the stiffer a polymeric material is, the less stretchable it has to be. “We are addressing a fundamental challenge that has been thought to be impossible to solve since the invention of vulcanized rubber in 1839,” said Liheng Cai, an assistant professor of materials science and engineering, and chemical engineering. That’s when Charles Goodyear accidentally discovered that heating natural rubber with sulfur ...

Wyoming research shows early North Americans made needles from fur-bearers

Wyoming research shows early North Americans made needles from fur-bearers
2024-11-27
A Wyoming archaeological site where people killed or scavenged a Columbian mammoth nearly 13,000 years ago has produced yet another discovery that sheds light on the life of these early inhabitants of North America. Wyoming State Archaeologist Spencer Pelton and colleagues at the University of Wyoming and other institutions have found that these Paleolithic humans made needles from the bones of fur-bearers -- including foxes; hares or rabbits; and cats such as bobcats, mountain lions, lynx and possibly even the now-extinct ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Clinical trial at Emory University reveals twice-yearly injection to be 96% effective in HIV prevention